Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1418, 2003-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Stenting worth it, but value of abciximab uncertain
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 443, 2003-01 ,pp. :
Access to resources
Recommend
Abciximab + stenting worth its cost?
Inpharma, Vol. 1, Iss. 1306, 2001-01 ,pp. :
Abciximab + stenting worth its cost?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 331, 2001-01 ,pp. :
Abciximab to tirofiban switch not worth it
Inpharma, Vol. 1, Iss. 1412, 2003-01 ,pp. :
Stenting ± abciximab more effective in acute MI
Inpharma, Vol. 1, Iss. 1332, 2002-01 ,pp. :